UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012–2017)

Diagnostic microbiology and infectious disease, 2020-06, Vol.97 (2), p.115016-115016, Article 115016

2020

Volltextzugriff (PDF)

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata : an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program

Diagnostic microbiology and infectious disease, 2010-06, Vol.67 (2), p.162-171

2010

Volltextzugriff (PDF)

Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods

Diagnostic microbiology and infectious disease, 2010-05, Vol.67 (1), p.56-60

2010

Volltextzugriff (PDF)

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis

Diagnostic microbiology and infectious disease, 2006-07, Vol.55 (3), p.209-212

2006

Volltextzugriff (PDF)

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

Diagnostic microbiology and infectious disease, 2011-07, Vol.70 (3), p.330-343

2011

Volltextzugriff (PDF)

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method

Diagnostic microbiology and infectious disease, 2011-11, Vol.71 (3), p.252-259

2011

Volltextzugriff (PDF)

Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values

Diagnostic microbiology and infectious disease, 2013-09, Vol.77 (1), p.37-40

2013

Volltextzugriff (PDF)

Concordance of nasal and diabetic foot ulcer staphylococcal colonization

Diagnostic microbiology and infectious disease, 2014-05, Vol.79 (1), p.85-89

2014

Volltextzugriff (PDF)

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection

Diagnostic microbiology and infectious disease, 2008-03, Vol.60 (3), p.273-277

2008

Volltextzugriff (PDF)

Plasmid-borne vga (A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States

Diagnostic microbiology and infectious disease, 2011-10, Vol.71 (2), p.177-180

2011

Volltextzugriff (PDF)

Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection

Diagnostic microbiology and infectious disease, 2009-06, Vol.64 (2), p.152-157

2009

Volltextzugriff (PDF)

Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program

Diagnostic microbiology and infectious disease, 2009-09, Vol.65 (1), p.27-34

2009

Volltextzugriff (PDF)

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp

Diagnostic microbiology and infectious disease, 2009-02, Vol.63 (2), p.233-236

2009

Volltextzugriff (PDF)

Response to Letter to the Editor

Diagnostic microbiology and infectious disease, 2008-07, Vol.61 (3), p.364-364

2008

Volltextzugriff (PDF)

Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?

Diagnostic microbiology and infectious disease, 2004-06, Vol.49 (2), p.141-145

2004

Volltextzugriff (PDF)

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against Gram-positive organisms isolated at 10 cancer-treatment centers

Diagnostic microbiology and infectious disease, 1999-05, Vol.34 (1), p.37-43

1999

Volltextzugriff (PDF)

Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals

Diagnostic microbiology and infectious disease, 1999-09, Vol.35 (1), p.81-88

1999

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Zeitschrift / SerieDiagnostic Microbiology And Infectious Disease

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(17)
IngentaConnect Journals
(17)
Elsevier ScienceDirect Journals
(17)
MEDLINE
(15)
Standalone journals
(0)

Menü

Weitere Dienste

Einstellungen

Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012–2017)

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata : an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program

Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method

Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values

Concordance of nasal and diabetic foot ulcer staphylococcal colonization

Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection

Plasmid-borne vga (A)-encoding gene in methicillin-resistant Staphylococcus aureus ST398 recovered from swine and a swine farmer in the United States

Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection

Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp

Response to Letter to the Editor

Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?

Antimicrobial activity of gatifloxacin compared to seven other compounds tested against Gram-positive organisms isolated at 10 cancer-treatment centers

Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals

Aktive Filter

Suchergebnisse filtern